Background-The cytoskeleton actin network of intestinal microvilli has been found to be rapidly impaired after gluten challenge in coeliac disease (CD). The aim of this study was to investigate the presence of an immune reaction towards cytoskeleton structures such as actin filaments in CD. Methods-Eighty three antiendomysial antibody positive CD patients (52 children and 31 adults) were studied at our outpatient clinics from 1996 to 1998 using indirect immunofluorescence, ELISA, and western blotting for antiactin (AAA) and antitissue transglutaminase (TGA) antibodies before and after a gluten free diet (GFD). Sixteen patients with smooth muscle antibody positive autoimmune hepatitis, 21 with inflammatory bowel diseases, seven with small bowel bacterial overgrowth, and 60 healthy subjects were studied as controls. Results-Fifty nine of 83 CD patients (28/31 adults (90.3%); 31/52 children (59.6%)) were positive for IgA and/or IgG AAA. Seventy seven (92.7%) were positive for IgA TGA. IgA AAA were strongly correlated with more severe degrees of intestinal villous atrophy (p<0.0001; relative risk 86.17). After a GFD, AAA became undetectable within five months. Conclusions-Apart from the immune reaction against the extracellular matrix, we have described an immune reaction against the cytoskeleton in both children and adults with CD. As AAA are strongly associated with more severe degrees of villous atrophy, they may represent a useful serological marker of severe intestinal atrophy in CD. (Gut 2000;47:520-526) 
Coeliac disease (CD) is a gluten sensitive enteropathy characterised by inflammation of the small bowel mucosa, with various degrees of intestinal villous atrophy and crypt hyperplasia, and by circulating antibodies (IgA and IgG class antigliadin (AGA), IgA antireticulin (ARA), and antiendomysium (AEA)). [1] [2] [3] Its clinical presentation is highly variable, ranging from silent to fully expressed intestinal malabsorption. 4 A strong association with HLA-DQ2 5 and a high prevalence of autoimmune diseases, such as insulin dependent diabetes mellitus and Hashimoto's thyroiditis, are typical CD features. 6 According to the ESPGHAN criteria, a diagnosis of CD is based on the histological picture and confirmed by demonstration of gluten dependence of the clinical symptoms and circulating antibodies. 7 Still largely unknown are the pathogenetic mechanisms by which dietary gluten in CD patients gives rise to the histological picture of flat mucosa, characterised by tissue destruction and reorganisation of the surface epithelium, basal lamina, and structures of the extracellular matrix. 8 Recently, tissue transglutaminase (tTG) has been identified as the major endomysial autoantigen 9 and evidence has been produced that deamidation of gliadin by tTG may enhance the recognition of gliadin peptides by HLA DQ2/8 T cells in genetically predisposed subjects and initiate the autoimmune disease. 10 Possible explanations for the matrix remodelling and mucosal damage in CD have been put forward. Activation of gliadin induced T cells could be responsible for mucosal destruction through production of cytokines and matrix metalloproteinases. 11 12 The involvement of the cytoskeleton in CD has been reported, 13 and gluten challenge has been shown to cause rapid disappearance and disorganisation of actin filaments on the intestinal mucosa from CD patients. 14 15 Furthermore, it has been shown recently that in human vascular smooth muscle cells, more than 40% of tTG activity colocalised with actin stress fibres. 16 The aim of this study was to investigate if a humoral immune reaction against actin, a key structural protein of the cytoskeleton network that is particularly abundant in intestinal microvilli, 17 is present in CD.
Materials and methods

PATIENTS
Eighty three biopsy proven coeliac patients, 52 children (mean age 5.9 (3.6) years, range 1-15; M/F 20/32) and 31 adults (mean age 31.1 (11.0) years, range 17-64; M/F 5/26) were included in the study. Nineteen patients had gluten sensitive liver involvement, represented by mild chronic hepatitis 18 in six patients or a fluctuating pattern of elevation of alanine aminotransferase (1.2-1.5 normal values). Three had associated insulin dependent diabetes mellitus and four were aVected by Down's syndrome. Sixteen patients with antismooth muscle antibody (SMA) positive autoimmune hepatitis (AH), seven with small bowel bacterial overgrowth, 21 with inflammatory bowel diseases (IBD) (12 with Crohn's disease and nine with ulcerative colitis) and 60 sex and age matched healthy volunteers were used as controls.
The AH and IBD patients were receiving immunosuppressive treatments (prednisone alone or associated with azathioprine). Detection of AGA, AEA, and antiactin antibodies (AAA) was therefore performed retrospectively on sera collected and stored at −20°C before a gluten free diet (GFD) (CD patients) or immunosuppressive therapy (AH, IBD), with blinded evaluation.
The mouse monoclonal antitissue transglutaminase antibody (NeoMarkers, Union City, California, USA) and the aYnity isolated rabbit AAA (Sigma Chemical, St Louis, Missouri, USA) were used as positive controls in all experiments.
INDIRECT IMMUNOFLUORESCENCE (IF) Unfixed tissue sections (monkey oesophagus sections, ImmunoPharmacology Research Spa, CT, Italy, for AEA detection; rat kidney, liver and stomach sections, Scimedx, Denville, New Jersey, USA, for SMA, ARA, antiliver kidney microsome antibody (LKM), antiliver cytosol 1 antibody (LC-1), and antimitochondrial antibody (AMA) detection; HEp-2 cells, MarDx diagnostics, Carlsbad, California, USA, for antinuclear antibody (ANA) and AAA detection; and ethanol and formaldehyde fixed neutrophils, Euroimmun, Lubeck, Germany, for antineutrophil cytoplasm antibody (ANCA) detection) were incubated at room temperature for 30 minutes with serum serial dilutions (from 1:5 to 1:1280 for AEA and ANCA, and from 1:40 to 1:1280 for all other autoantibodies) in a covered moist chamber, washed twice in phosphate buVered saline (PBS) solutions for five minutes, incubated at room temperature for 30 minutes with FITC conjugate goat antihuman sera (IgA+IgG+IgM or anti-IgA or anti-IgG, Kallestad, Austin, Texas, USA) diluted 1:100 in PBS, washed twice as before, and read with an Orthoplan fluorescence microscope (Leitz, Wetzlar, Germany).
The mouse monoclonal anti-TG antibody and the rabbit AAA were used at a 1:50 dilution during the first incubation followed by a second incubation with the 1:100 diluted FITC conjugate antimouse or antirabbit immunoglobulins (Sigma). ENZYME IMMUNOASSAY (ELISA) Detection of AGA was performed using a commercial kit (Pharmacia and Upjohn Diagnostic AB, Uppsala, Sweden). Detection of antitransglutaminase antibodies (TGA) and AAA was performed using an ELISA as described previously. 19 Flat bottomed well microtitre plates (Greiner Laboratory, Greiner, Germany) were coated with a 10 µg/ml PBS solution (50 µl/well) of bovine muscle actin (Sigma) or guinea pig liver transglutaminase (Sigma). Stopped reactions were read at 492 nm by a microtitre plate reader (DPC, USA). The normal mean value (N) displayed by healthy control sera was 0.050 (0.020) (median 0.050). The threshold was fixed at 2 N (0.100).
The control wells (no serum) introduced in each plate displayed an absorbance of <0.025. A serum sample was considered positive when it exceeded twice (>0.100) the absorbance mean value observed with normal control sera.
WESTERN BLOTTING
Purified proteins (bovine muscle actin and guinea pig liver transglutaminase; Sigma) were separated by 10% sodium dodecyl sulphatepolyacrylamide gel electrophoresis and transferred onto nitrocellulose filters. 19 20 The filters were blocked for one hour in a PBS 0.1% Tween 20, 5% non-fat dry milk solution, incubated for one hour at room temperature with patients' sera at a 1:100 dilution and successively incubated for one hour at room temperature with a 1:1000 dilution of alkaline phosphatase conjugated antihuman IgG+IgM+IgA antiserum (ICN Biomedicals, Aurora, Ohio, USA). The NBT/BCIP detection system (Promega, Madison, Wisconsin, USA) was used to develop the filters. 20 The mouse anti-TG and rabbit AAA were used at a 1:100 dilution, the alkaline phosphatase conjugate antimouse or antirabbit immunoglobulins (Sigma) at 1:1000 dilution.
ABSORPTION EXPERIMENTS
Absorption experiments were performed with bovine muscle actin 21 and guinea pig liver transglutaminase, 9 separately, using five sera positive for both TGA and AAA. Sera were incubated overnight under continuous shaking with bovine muscle actin or guinea pig liver transglutaminase at a concentration of 10-100 mg of protein/ml of undiluted serum. The solution was then ultracentrifuged at 100 000 g for 30 minutes.
IF of HEp-2 cells was carried out before and after absorption sera with bovine muscle actin or tTG.
HISTOLOGICAL EVALUATION
The degree of crypt hyperplastic villous atrophy was evaluated according to Murch Figure 1A shows typical AAA immunostaining where the actin filaments appear as long parallel filaments spanning the axis of cells and crossing the nucleus. IF of HEp-2 cells performed with the monoclonal anti-tTG antibody did not show any positivity (fig 1B) .
Actin stress fibre immunostaining disappeared almost completely after absorption with bovine muscle actin ( fig 1C, 1D ) but remained unchanged after absorption with tTG (data not shown), confirming the antigen specificity of this reaction.
The AAA disappeared in all patients within the first five months on a GFD (tables 1, 2, 3) , that is, later than AGA but earlier than AEA (data not shown).
Eighteen of 59 coeliac sera reacted with monomeric actin, as demonstrated by western blotting and ELISA. Figure 2 shows the results of western blotting obtained with sera from coeliac patient Nos 13 (see table 3) and 2 (see  table 2 ). Sera reacted distinctly with the 78 kDa protein band of tTG (fig 2, No 2 ) and with the 42 kDa protein band of the monomeric actin (fig 2, No 4) .
A high correlation (r s 0.64; gamma 0.90; p<0.0001) was observed between AAA positivity and the degree of histological villous atrophy, with 49 AAA positive patients showing severe and 10 moderate degrees of villous atrophy (tables 1, 2, 3 Twenty three (27.7%) CD patients were ANA positive. No association was found between ANA positivity and degree of villous atrophy (ns) or the presence of liver involvement (ns).
None of the coeliac patients was positive for ANCA, LKM, AMA, antisoluble liver antigen antibodies (SLA), or LC-1 antibodies.
CONTROL GROUPS
AH patients All 16 SMA positive AH patients enrolled in the study were AAA positive. AAA were of the IgG type in all patients (titre range 1:40 to >1:1280). Only two AH patients reacted with monomeric actin on western blotting or ELISA (data not shown). None was positive for AGA and/or AEA. Eighty five per cent of AH patients were also pANCA positive.
IBD patients, small bowel bacterial overgrowth, and healthy controls
None of the IBD, small bowel overgrowth, or healthy controls was IgA-AAA positive. Two of nine patients with ulcerative colitis showed IgG-AAA at low titre (1:5). ANCA were positive in five patients with ulcerative colitis (pANCA) and in three patients with Crohn's disease (two pANCA, one cANCA).
Discussion
We have described for the first time gluten dependent serum autoantibodies against actin in CD. This immune reaction is clearly distinct from those of the extracellular matrix of the lamina propria and the endomysium of muscularis mucosa, whose main target antigen has recently been identified as tTG. 9 In predisposed subjects, tTG by gliadin deamidation and by the formation of the gliadin-tTG complex may enhance mucosal T cell activation and production of cytokines and matrix metalloproteinases that cause damage to the intestinal mucosa. [10] [11] [12] The immune reaction against the cytoskeleton in our CD patients was found to be associated with more severe degrees of intestinal villous atrophy, and to be age related as it was observed more frequently in our CD adult patients than in children. The close link between the presence of AAA and the severity and persistence of tissue damage suggests that AAA could be secondary to intestinal mucosa damage in that it unmasks cryptic antigens. According to this hypothesis other tissue antigens may become increasingly exposed to the immune system as a result of continued gluten ingestion thus leading to the production of increasing numbers of autoantibodies in predisposed subjects. Indeed, autoantibodies against human calreticulin, an endoplasmic reticulum luminal protein, 24 and recently auto- antibodies against zonulin, a newly described enterocyte protein, have been detected in untreated CD patients. 25 Moreover, preliminary results from our study (data not shown) reveal the presence of IgA antibodies to gelsolin, an actin severing and capping protein, in 30% of AAA positive CD patients (unpublished results).
Furthermore, gluten challenge in CD patients has been described as causing a very early reduction and disorganisation of enterocyte actin filaments. 14 15 Thus impairment of the cytoskeleton network per se could induce further mucosal damage and apoptosis, [26] [27] [28] aggravating immune mediated tissue damage. In fact, the activity of genes encoding for proteins involved in the structure (type I collagen and fibronectin), turnover (collagenase and tissue inhibitor of metalloproteinase 1), and regulation (transforming growth factor ) of the extracellular matrix is governed, at least partly, by the status of the cytoskeleton. 29 Moreover, as serum AAA positivity has been found to have a high RR for severe villous atrophy, AAA could represent a useful serological marker of intestinal mucosal damage in coeliac patients.
In our study, among the intestinal diseases characterised by immuno mediated tissue damage, IgA-AAA appear to be associated with CD, while they are negative in IBD, which are predominantly characterised by IgG-pANCA. 30 Only two IBD patients showed AA autoantibodies; however, they were of the IgG type, at a low titre, and not associated with AEA or TGA.
Liver involvement in our CD patients is another moot point. The problem of liver damage in association with CD has been outlined since 1977, and serological screening for antigliadin has long been recommended in patients with cryptogenic hepatitis. [31] [32] [33] Nevertheless, complete analysis of the major autoantibodies that characterise the various forms of chronic hepatitis (that is, ANA, SMA, AAA, LKM, AMA, SLA, LC-1, and ANCA) 18 has never been carried out in CD. 33 In our study most coeliac patients with associated liver involvement had positive AAA of either the IgG or the IgA type or both, while analysis of other autoantibodies associated with chronic hepatitis proved negative.
As described in patients aVected by AH, 34 AAA detected in CD seem to be specific for polymerised actin, and IF of fibroblasts or HEp-2cells represents the most widely used method of AAA detection. 34 35 In fact only a few of our patients, in the CD and AH groups, reacted with unpolymerised actin in the western blotting and ELISA experiments. This may be attributable to the high epitope density in polymerised actin. 21 The monomeric actin that produced negative results on ELISA and western blotting was the same form of protein that allowed preabsorption of patient sera. It may be contradictory, but the high monomeric actin concentration used for absorption experiments promotes the formation of actin filaments. 36 While in AH, IgG AAA were the most predominant class, AAA in CD were mostly of the IgA type. Furthermore, unlike severe hepatitis in AH patients, chronic hepatitis in all our coeliac patients was mild, with no hypergammaglobulinaemia, and responsive to a GFD. Therefore, a diagnosis of CD should be considered based on AGA and AEA investigations in all patients with chronic hepatitis, particularly in the presence of AAA positivity. A small bowel biopsy in positive patients will allow selection of patients that should be placed on a GFD.
In conclusion, our study is the first to describe an immune reaction against actin filaments in children and adult CD patients. From a practical point of view, the availability of a further serological marker could be useful in directing diagnostic suspicion towards CD. Further studies will help confirm the presence of AAA in the sera of coeliac patients as a marker of moderate or severe intestinal mucosal villous atrophy.
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